Open Peer Review Reports for: Pharmacological effects of N -[2-[[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]ethyl]hyaluronamide (diclofenac Etalhyaluronate, SI-613), a novel sodium hyaluronate derivative chemically linked with diclofenac
Pre-publication versions of this article are available by contacting info@biomedcentral.com.
| Original Submission | ||
|---|---|---|
| 2 Nov 2017 | Submitted | Original manuscript |
| 22 Nov 2017 | Reviewed | Reviewer Report - Ellen Wasan |
| 20 Mar 2018 | Author responded | Author comments - Keiji Yoshioka |
| Resubmission - Version 2 | ||
| 20 Mar 2018 | Submitted | Manuscript version 2 |
| 26 Apr 2018 | Author responded | Author comments - Keiji Yoshioka |
| Resubmission - Version 3 | ||
| 26 Apr 2018 | Submitted | Manuscript version 3 |
| Publishing | ||
| 7 May 2018 | Editorially accepted | |
| 22 May 2018 | Article published | 10.1186/s12891-018-2077-8 |
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.
You can find further information about the peer review system here.
